The global market for Totally Implantable Venous Access Port (TIVAP) was valued at US$ 565 million in the year 2024 and is projected to reach a revised size of US$ 680 million by 2031, growing at a CAGR of 2.7% during the forecast period.

Totally Implantable Venous Access Port (TIVAP) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Totally Implantable Venous Access Port (TIVAP) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A Totally Implantable Venous Access Port (TIVAP) is a medical device designed for long-term intravenous (IV) therapy, providing a secure and convenient access point to the vascular system. Surgically implanted beneath the skin, usually in the chest area, the TIVAP consists of a reservoir and a catheter. The reservoir is accessed through the skin using a specialized needle, allowing healthcare professionals to administer medications, fluids, or draw blood without the need for repeated needle insertions. TIVAPs are commonly used in cancer treatment, chemotherapy, long-term antibiotic therapy, and other medical conditions requiring frequent or continuous intravenous interventions. This implantable device reduces the discomfort associated with repeated needle sticks and minimizes the risk of infection, providing a reliable and efficient means of delivering medical treatments directly into the bloodstream.

The market for Totally Implantable Venous Access Ports (TIVAPs) is being driven by the growing global burden of chronic diseases, particularly cancer, which often necessitates long-term intravenous therapies such as chemotherapy, parenteral nutrition, and repeated blood sampling. TIVAPs offer a more convenient and safer alternative to peripheral intravenous access, significantly reducing patient discomfort and lowering the risk of infections over extended treatment periods. As cancer cases continue to rise globally—especially among aging populations—the demand for effective, long-term vascular access devices like TIVAPs is increasing. In addition, technological advancements in port materials, catheter designs, and minimally invasive implantation techniques have made these devices more patient-friendly and efficient. Improvements such as MRI-compatibility, reduced port sizes, and antimicrobial coatings contribute to enhanced clinical outcomes and wider adoption. Furthermore, increasing investments in healthcare infrastructure, particularly in developing economies, and favorable reimbursement policies in developed regions are supporting market growth. Educational efforts by healthcare providers to raise awareness about the benefits of TIVAPs are also playing a crucial role in expanding their use across oncology, hematology, and other medical fields.

Despite their clinical benefits, the market for Totally Implantable Venous Access Ports faces several notable challenges. One of the primary concerns is the high cost associated with TIVAP implantation, maintenance, and potential complications, which can limit accessibility in cost-sensitive or under-resourced healthcare settings. The requirement for surgical implantation and removal of the port necessitates trained medical professionals and sterile operating conditions, which may not be readily available in rural or low-income areas. Additionally, while TIVAPs reduce the risk of infection compared to external catheters, complications such as thrombosis, catheter occlusion, and device malfunctions still pose risks that may impact patient safety and increase healthcare costs. Another barrier to market expansion is the variability in regulatory frameworks and approval processes across different countries, which can delay the launch of innovative products. Moreover, the need for patient education and caregiver training for proper port care in outpatient settings remains a logistical challenge, especially in regions where healthcare literacy is low. Lastly, competition from alternative venous access devices—such as PICC lines and external tunneled catheters—may restrain market growth, particularly in situations where short- to medium-term venous access is sufficient. Addressing these issues through better training, cost-effective innovations, and global regulatory harmonization will be essential for unlocking the full market potential of TIVAPs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Totally Implantable Venous Access Port (TIVAP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Totally Implantable Venous Access Port (TIVAP).

The Totally Implantable Venous Access Port (TIVAP) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Totally Implantable Venous Access Port (TIVAP) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Totally Implantable Venous Access Port (TIVAP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Totally Implantable Venous Access Port (TIVAP) Market Report

Report Metric	Details
Report Name	Totally Implantable Venous Access Port (TIVAP) Market
Accounted market size in year	US$ 565 million
Forecasted market size in 2031	US$ 680 million
CAGR	2.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Titanium Chamber Silicone Chamber Others
Segment by Application	Intravenous Chemotherapy Nutrition Support Therapy Contrast Media Injection
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	BD, AngioDynamics, ICU Medical, B. Braun Medical, PFM Medical, Vygon, Districlass, PakuMed, Linhua Medical, Fresenius, Sophysa, Baxter
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Totally Implantable Venous Access Port (TIVAP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Totally Implantable Venous Access Port (TIVAP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Totally Implantable Venous Access Port (TIVAP) Market growing?

Ans: The Totally Implantable Venous Access Port (TIVAP) Market witnessing a CAGR of 2.7% during the forecast period 2025-2031.

What is the Totally Implantable Venous Access Port (TIVAP) Market size in 2031?

Ans: The Totally Implantable Venous Access Port (TIVAP) Market size in 2031 will be US$ 680 million.

Who are the main players in the Totally Implantable Venous Access Port (TIVAP) Market report?

Ans: The main players in the Totally Implantable Venous Access Port (TIVAP) Market are BD, AngioDynamics, ICU Medical, B. Braun Medical, PFM Medical, Vygon, Districlass, PakuMed, Linhua Medical, Fresenius, Sophysa, Baxter

What are the Application segmentation covered in the Totally Implantable Venous Access Port (TIVAP) Market report?

Ans: The Applications covered in the Totally Implantable Venous Access Port (TIVAP) Market report are Intravenous Chemotherapy, Nutrition Support Therapy, Contrast Media Injection

What are the Type segmentation covered in the Totally Implantable Venous Access Port (TIVAP) Market report?

Ans: The Types covered in the Totally Implantable Venous Access Port (TIVAP) Market report are Titanium Chamber, Silicone Chamber, Others

1 Totally Implantable Venous Access Port (TIVAP) Market Overview

1.1 Product Definition

1.2 Totally Implantable Venous Access Port (TIVAP) by Type

1.2.1 Global Totally Implantable Venous Access Port (TIVAP) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Titanium Chamber

1.2.3 Silicone Chamber

1.2.4 Others

1.3 Totally Implantable Venous Access Port (TIVAP) by Application

1.3.1 Global Totally Implantable Venous Access Port (TIVAP) Market Value by Application (2024 VS 2031)

1.3.2 Intravenous Chemotherapy

1.3.3 Nutrition Support Therapy

1.3.4 Contrast Media Injection

1.4 Global Totally Implantable Venous Access Port (TIVAP) Market Size Estimates and Forecasts

1.4.1 Global Totally Implantable Venous Access Port (TIVAP) Revenue 2020-2031

1.4.2 Global Totally Implantable Venous Access Port (TIVAP) Sales 2020-2031

1.4.3 Global Totally Implantable Venous Access Port (TIVAP) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Totally Implantable Venous Access Port (TIVAP) Market Competition by Manufacturers

2.1 Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Totally Implantable Venous Access Port (TIVAP) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Totally Implantable Venous Access Port (TIVAP), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Totally Implantable Venous Access Port (TIVAP), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Totally Implantable Venous Access Port (TIVAP), Product Type & Application

2.7 Global Key Manufacturers of Totally Implantable Venous Access Port (TIVAP), Date of Enter into This Industry

2.8 Global Totally Implantable Venous Access Port (TIVAP) Market Competitive Situation and Trends

2.8.1 Global Totally Implantable Venous Access Port (TIVAP) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Totally Implantable Venous Access Port (TIVAP) Players Market Share by Revenue

2.8.3 Global Totally Implantable Venous Access Port (TIVAP) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Totally Implantable Venous Access Port (TIVAP) Market Scenario by Region

3.1 Global Totally Implantable Venous Access Port (TIVAP) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Totally Implantable Venous Access Port (TIVAP) Sales by Region: 2020-2031

3.2.1 Global Totally Implantable Venous Access Port (TIVAP) Sales by Region: 2020-2025

3.2.2 Global Totally Implantable Venous Access Port (TIVAP) Sales by Region: 2026-2031

3.3 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Region: 2020-2031

3.3.1 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Region: 2020-2025

3.3.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Region: 2026-2031

3.4 North America Totally Implantable Venous Access Port (TIVAP) Market Facts & Figures by Country

3.4.1 North America Totally Implantable Venous Access Port (TIVAP) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2031)

3.4.3 North America Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Totally Implantable Venous Access Port (TIVAP) Market Facts & Figures by Country

3.5.1 Europe Totally Implantable Venous Access Port (TIVAP) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2031)

3.5.3 Europe Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Totally Implantable Venous Access Port (TIVAP) Market Facts & Figures by Region

3.6.1 Asia Pacific Totally Implantable Venous Access Port (TIVAP) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Totally Implantable Venous Access Port (TIVAP) Sales by Region (2020-2031)

3.6.3 Asia Pacific Totally Implantable Venous Access Port (TIVAP) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Totally Implantable Venous Access Port (TIVAP) Market Facts & Figures by Country

3.7.1 Latin America Totally Implantable Venous Access Port (TIVAP) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2031)

3.7.3 Latin America Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Market Facts & Figures by Country

3.8.1 Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Totally Implantable Venous Access Port (TIVAP) Sales by Type (2020-2031)

4.1.1 Global Totally Implantable Venous Access Port (TIVAP) Sales by Type (2020-2025)

4.1.2 Global Totally Implantable Venous Access Port (TIVAP) Sales by Type (2026-2031)

4.1.3 Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Type (2020-2031)

4.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Type (2020-2031)

4.2.1 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Type (2020-2025)

4.2.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Type (2026-2031)

4.2.3 Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Type (2020-2031)

4.3 Global Totally Implantable Venous Access Port (TIVAP) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Totally Implantable Venous Access Port (TIVAP) Sales by Application (2020-2031)

5.1.1 Global Totally Implantable Venous Access Port (TIVAP) Sales by Application (2020-2025)

5.1.2 Global Totally Implantable Venous Access Port (TIVAP) Sales by Application (2026-2031)

5.1.3 Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Application (2020-2031)

5.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Application (2020-2031)

5.2.1 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Application (2020-2025)

5.2.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Application (2026-2031)

5.2.3 Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Application (2020-2031)

5.3 Global Totally Implantable Venous Access Port (TIVAP) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 BD

6.1.1 BD Company Information

6.1.2 BD Description and Business Overview

6.1.3 BD Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 BD Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.1.5 BD Recent Developments/Updates

6.2 AngioDynamics

6.2.1 AngioDynamics Company Information

6.2.2 AngioDynamics Description and Business Overview

6.2.3 AngioDynamics Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 AngioDynamics Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.2.5 AngioDynamics Recent Developments/Updates

6.3 ICU Medical

6.3.1 ICU Medical Company Information

6.3.2 ICU Medical Description and Business Overview

6.3.3 ICU Medical Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 ICU Medical Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.3.5 ICU Medical Recent Developments/Updates

6.4 B. Braun Medical

6.4.1 B. Braun Medical Company Information

6.4.2 B. Braun Medical Description and Business Overview

6.4.3 B. Braun Medical Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 B. Braun Medical Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.4.5 B. Braun Medical Recent Developments/Updates

6.5 PFM Medical

6.5.1 PFM Medical Company Information

6.5.2 PFM Medical Description and Business Overview

6.5.3 PFM Medical Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 PFM Medical Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.5.5 PFM Medical Recent Developments/Updates

6.6 Vygon

6.6.1 Vygon Company Information

6.6.2 Vygon Description and Business Overview

6.6.3 Vygon Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Vygon Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.6.5 Vygon Recent Developments/Updates

6.7 Districlass

6.7.1 Districlass Company Information

6.7.2 Districlass Description and Business Overview

6.7.3 Districlass Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Districlass Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.7.5 Districlass Recent Developments/Updates

6.8 PakuMed

6.8.1 PakuMed Company Information

6.8.2 PakuMed Description and Business Overview

6.8.3 PakuMed Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 PakuMed Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.8.5 PakuMed Recent Developments/Updates

6.9 Linhua Medical

6.9.1 Linhua Medical Company Information

6.9.2 Linhua Medical Description and Business Overview

6.9.3 Linhua Medical Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Linhua Medical Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.9.5 Linhua Medical Recent Developments/Updates

6.10 Fresenius

6.10.1 Fresenius Company Information

6.10.2 Fresenius Description and Business Overview

6.10.3 Fresenius Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Fresenius Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.10.5 Fresenius Recent Developments/Updates

6.11 Sophysa

6.11.1 Sophysa Company Information

6.11.2 Sophysa Description and Business Overview

6.11.3 Sophysa Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Sophysa Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.11.5 Sophysa Recent Developments/Updates

6.12 Baxter

6.12.1 Baxter Company Information

6.12.2 Baxter Description and Business Overview

6.12.3 Baxter Totally Implantable Venous Access Port (TIVAP) Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Baxter Totally Implantable Venous Access Port (TIVAP) Product Portfolio

6.12.5 Baxter Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Totally Implantable Venous Access Port (TIVAP) Industry Chain Analysis

7.2 Totally Implantable Venous Access Port (TIVAP) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Totally Implantable Venous Access Port (TIVAP) Production Mode & Process Analysis

7.4 Totally Implantable Venous Access Port (TIVAP) Sales and Marketing

7.4.1 Totally Implantable Venous Access Port (TIVAP) Sales Channels

7.4.2 Totally Implantable Venous Access Port (TIVAP) Distributors

7.5 Totally Implantable Venous Access Port (TIVAP) Customer Analysis

8 Totally Implantable Venous Access Port (TIVAP) Market Dynamics

8.1 Totally Implantable Venous Access Port (TIVAP) Industry Trends

8.2 Totally Implantable Venous Access Port (TIVAP) Market Drivers

8.3 Totally Implantable Venous Access Port (TIVAP) Market Challenges

8.4 Totally Implantable Venous Access Port (TIVAP) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Totally Implantable Venous Access Port (TIVAP) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Totally Implantable Venous Access Port (TIVAP) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Totally Implantable Venous Access Port (TIVAP) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Totally Implantable Venous Access Port (TIVAP) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Totally Implantable Venous Access Port (TIVAP) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Totally Implantable Venous Access Port (TIVAP) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Totally Implantable Venous Access Port (TIVAP) Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Totally Implantable Venous Access Port (TIVAP), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Totally Implantable Venous Access Port (TIVAP), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Totally Implantable Venous Access Port (TIVAP), Product Type & Application

Table 12. Global Key Manufacturers of Totally Implantable Venous Access Port (TIVAP), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Totally Implantable Venous Access Port (TIVAP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Totally Implantable Venous Access Port (TIVAP) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Totally Implantable Venous Access Port (TIVAP) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Totally Implantable Venous Access Port (TIVAP) Sales by Region (2020-2025) & (K Units)

Table 18. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Region (2020-2025)

Table 19. Global Totally Implantable Venous Access Port (TIVAP) Sales by Region (2026-2031) & (K Units)

Table 20. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Region (2026-2031)

Table 21. Global Totally Implantable Venous Access Port (TIVAP) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Region (2020-2025)

Table 23. Global Totally Implantable Venous Access Port (TIVAP) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Region (2026-2031)

Table 25. North America Totally Implantable Venous Access Port (TIVAP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2025) & (K Units)

Table 27. North America Totally Implantable Venous Access Port (TIVAP) Sales by Country (2026-2031) & (K Units)

Table 28. North America Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Totally Implantable Venous Access Port (TIVAP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Totally Implantable Venous Access Port (TIVAP) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Totally Implantable Venous Access Port (TIVAP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Totally Implantable Venous Access Port (TIVAP) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Totally Implantable Venous Access Port (TIVAP) Sales (K Units) by Type (2020-2025)

Table 51. Global Totally Implantable Venous Access Port (TIVAP) Sales (K Units) by Type (2026-2031)

Table 52. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Type (2020-2025)

Table 53. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Type (2026-2031)

Table 54. Global Totally Implantable Venous Access Port (TIVAP) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Totally Implantable Venous Access Port (TIVAP) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Type (2020-2025)

Table 57. Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Type (2026-2031)

Table 58. Global Totally Implantable Venous Access Port (TIVAP) Price (US$/Unit) by Type (2020-2025)

Table 59. Global Totally Implantable Venous Access Port (TIVAP) Price (US$/Unit) by Type (2026-2031)

Table 60. Global Totally Implantable Venous Access Port (TIVAP) Sales (K Units) by Application (2020-2025)

Table 61. Global Totally Implantable Venous Access Port (TIVAP) Sales (K Units) by Application (2026-2031)

Table 62. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Application (2020-2025)

Table 63. Global Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Application (2026-2031)

Table 64. Global Totally Implantable Venous Access Port (TIVAP) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Totally Implantable Venous Access Port (TIVAP) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Application (2020-2025)

Table 67. Global Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Application (2026-2031)

Table 68. Global Totally Implantable Venous Access Port (TIVAP) Price (US$/Unit) by Application (2020-2025)

Table 69. Global Totally Implantable Venous Access Port (TIVAP) Price (US$/Unit) by Application (2026-2031)

Table 70. BD Company Information

Table 71. BD Description and Business Overview

Table 72. BD Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. BD Totally Implantable Venous Access Port (TIVAP) Product

Table 74. BD Recent Developments/Updates

Table 75. AngioDynamics Company Information

Table 76. AngioDynamics Description and Business Overview

Table 77. AngioDynamics Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. AngioDynamics Totally Implantable Venous Access Port (TIVAP) Product

Table 79. AngioDynamics Recent Developments/Updates

Table 80. ICU Medical Company Information

Table 81. ICU Medical Description and Business Overview

Table 82. ICU Medical Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. ICU Medical Totally Implantable Venous Access Port (TIVAP) Product

Table 84. ICU Medical Recent Developments/Updates

Table 85. B. Braun Medical Company Information

Table 86. B. Braun Medical Description and Business Overview

Table 87. B. Braun Medical Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. B. Braun Medical Totally Implantable Venous Access Port (TIVAP) Product

Table 89. B. Braun Medical Recent Developments/Updates

Table 90. PFM Medical Company Information

Table 91. PFM Medical Description and Business Overview

Table 92. PFM Medical Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. PFM Medical Totally Implantable Venous Access Port (TIVAP) Product

Table 94. PFM Medical Recent Developments/Updates

Table 95. Vygon Company Information

Table 96. Vygon Description and Business Overview

Table 97. Vygon Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Vygon Totally Implantable Venous Access Port (TIVAP) Product

Table 99. Vygon Recent Developments/Updates

Table 100. Districlass Company Information

Table 101. Districlass Description and Business Overview

Table 102. Districlass Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Districlass Totally Implantable Venous Access Port (TIVAP) Product

Table 104. Districlass Recent Developments/Updates

Table 105. PakuMed Company Information

Table 106. PakuMed Description and Business Overview

Table 107. PakuMed Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. PakuMed Totally Implantable Venous Access Port (TIVAP) Product

Table 109. PakuMed Recent Developments/Updates

Table 110. Linhua Medical Company Information

Table 111. Linhua Medical Description and Business Overview

Table 112. Linhua Medical Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Linhua Medical Totally Implantable Venous Access Port (TIVAP) Product

Table 114. Linhua Medical Recent Developments/Updates

Table 115. Fresenius Company Information

Table 116. Fresenius Description and Business Overview

Table 117. Fresenius Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Fresenius Totally Implantable Venous Access Port (TIVAP) Product

Table 119. Fresenius Recent Developments/Updates

Table 120. Sophysa Company Information

Table 121. Sophysa Description and Business Overview

Table 122. Sophysa Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Sophysa Totally Implantable Venous Access Port (TIVAP) Product

Table 124. Sophysa Recent Developments/Updates

Table 125. Baxter Company Information

Table 126. Baxter Description and Business Overview

Table 127. Baxter Totally Implantable Venous Access Port (TIVAP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Baxter Totally Implantable Venous Access Port (TIVAP) Product

Table 129. Baxter Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Totally Implantable Venous Access Port (TIVAP) Distributors List

Table 133. Totally Implantable Venous Access Port (TIVAP) Customers List

Table 134. Totally Implantable Venous Access Port (TIVAP) Market Trends

Table 135. Totally Implantable Venous Access Port (TIVAP) Market Drivers

Table 136. Totally Implantable Venous Access Port (TIVAP) Market Challenges

Table 137. Totally Implantable Venous Access Port (TIVAP) Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Totally Implantable Venous Access Port (TIVAP)

Figure 2. Global Totally Implantable Venous Access Port (TIVAP) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Totally Implantable Venous Access Port (TIVAP) Market Share by Type: 2024 & 2031

Figure 4. Titanium Chamber Product Picture

Figure 5. Silicone Chamber Product Picture

Figure 6. Others Product Picture

Figure 7. Global Totally Implantable Venous Access Port (TIVAP) Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Totally Implantable Venous Access Port (TIVAP) Market Share by Application: 2024 & 2031

Figure 9. Intravenous Chemotherapy

Figure 10. Nutrition Support Therapy

Figure 11. Contrast Media Injection

Figure 12. Global Totally Implantable Venous Access Port (TIVAP) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Totally Implantable Venous Access Port (TIVAP) Market Size (2020-2031) & (US$ Million)

Figure 14. Global Totally Implantable Venous Access Port (TIVAP) Sales (2020-2031) & (K Units)

Figure 15. Global Totally Implantable Venous Access Port (TIVAP) Average Price (US$/Unit) & (2020-2031)

Figure 16. Totally Implantable Venous Access Port (TIVAP) Report Years Considered

Figure 17. Totally Implantable Venous Access Port (TIVAP) Sales Share by Manufacturers in 2024

Figure 18. Global Totally Implantable Venous Access Port (TIVAP) Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Totally Implantable Venous Access Port (TIVAP) Players: Market Share by Revenue in Totally Implantable Venous Access Port (TIVAP) in 2024

Figure 20. Totally Implantable Venous Access Port (TIVAP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Totally Implantable Venous Access Port (TIVAP) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Country (2020-2031)

Figure 23. North America Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Country (2020-2031)

Figure 24. United States Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Country (2020-2031)

Figure 27. Europe Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Country (2020-2031)

Figure 28. Germany Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Region (2020-2031)

Figure 35. China Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Country (2020-2031)

Figure 43. Latin America Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Totally Implantable Venous Access Port (TIVAP) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Totally Implantable Venous Access Port (TIVAP) by Type (2020-2031)

Figure 53. Global Revenue Market Share of Totally Implantable Venous Access Port (TIVAP) by Type (2020-2031)

Figure 54. Global Totally Implantable Venous Access Port (TIVAP) Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Totally Implantable Venous Access Port (TIVAP) by Application (2020-2031)

Figure 56. Global Revenue Market Share of Totally Implantable Venous Access Port (TIVAP) by Application (2020-2031)

Figure 57. Global Totally Implantable Venous Access Port (TIVAP) Price (US$/Unit) by Application (2020-2031)

Figure 58. Totally Implantable Venous Access Port (TIVAP) Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-17U17968

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Sitagliptin Phosphate And Metformin Hydrochloride Tablets(Ⅱ) Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-23B17471

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Portable Electric Chemotherapy Pump Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-3C17964

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Specific IgE Blood Based Allergy Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-33D17671

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Totally Implantable Venous Access Port (TIVAP) Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-20P16459

Global Totally Implantable Venous Access Port (TIVAP) Market Research Report 2025

FEATURED COMPANIES

Totally Implantable Venous Access Port (TIVAP) Market Size

Totally Implantable Venous Access Port (TIVAP) Market

Report Scope

Scope of Totally Implantable Venous Access Port (TIVAP) Market Report

Core Chapters

FAQ for this report

How fast is Totally Implantable Venous Access Port (TIVAP) Market growing?

What is the Totally Implantable Venous Access Port (TIVAP) Market size in 2031?

Who are the main players in the Totally Implantable Venous Access Port (TIVAP) Market report?

What are the Application segmentation covered in the Totally Implantable Venous Access Port (TIVAP) Market report?

What are the Type segmentation covered in the Totally Implantable Venous Access Port (TIVAP) Market report?

FEATURED COMPANIES

RELATED REPORTS